The Antiparasitic Compound Licochalcone A Is a Potent Echinocytogenic Agent That Modifies the Erythrocyte Membrane in the Concentration Range Where Antiplasmodial Activity Is Observed
AUTOR(ES)
Ziegler, Hanne L.
FONTE
American Society for Microbiology
RESUMO
The well-known antiparasitic compound licochalcone A is a potent membrane-active agent that transforms normal erythrocytes into echinocytes in parallel with the inhibition of growth of Plasmodium falciparum cultures, the in vitro antiplasmodial effect apparently being an indirect effect on the host cell. In vitro experiments with synchronous cultures demonstrate that inhibition of invasion is the principal mechanism of growth inhibition. The erythrocyte membrane-modifying effect was also transiently observed in vivo in mice after intravenous administration.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=521868Documentos Relacionados
- Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
- Pegylated Leptin Antagonist Is a Potent Orexigenic Agent: Preparation and Mechanism of Activity
- Antiparasitic Agent Atovaquone
- beta-endorphin is a potent analgesic agent.
- The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria.